Literature DB >> 15319778

Molecular mechanisms in signal transduction and cancer.

Johannes L Bos1, Boudewijn M T Burgering.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15319778      PMCID： PMC1299131          DOI： 10.1038/sj.embor.7400220

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  11 in total

1.  Stepwise reprogramming of B cells into macrophages.

Authors:  Huafeng Xie; Min Ye; Ru Feng; Thomas Graf
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

Review 2.  The Hedgehog response network: sensors, switches, and routers.

Authors:  Lawrence Lum; Philip A Beachy
Journal:  Science       Date:  2004-06-18       Impact factor: 47.728

Review 3.  Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.

Authors:  Pipsa Saharinen; Tuomas Tammela; Marika J Karkkainen; Kari Alitalo
Journal:  Trends Immunol       Date:  2004-07       Impact factor: 16.687

4.  Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.

Authors:  Paul T C Wan; Mathew J Garnett; S Mark Roe; Sharlene Lee; Dan Niculescu-Duvaz; Valerie M Good; C Michael Jones; Christopher J Marshall; Caroline J Springer; David Barford; Richard Marais
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

5.  Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD.

Authors:  Annette F Baas; Jeroen Kuipers; Nicole N van der Wel; Eduard Batlle; Henk K Koerten; Peter J Peters; Hans C Clevers
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

6.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.

Authors:  Jose M Lizcano; Olga Göransson; Rachel Toth; Maria Deak; Nick A Morrice; Jérôme Boudeau; Simon A Hawley; Lina Udd; Tomi P Mäkelä; D Grahame Hardie; Dario R Alessi
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

7.  Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.

Authors:  Aaron Aslanian; Phillip J Iaquinta; Raluca Verona; Jacqueline A Lees
Journal:  Genes Dev       Date:  2004-06-02       Impact factor: 11.361

8.  Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.

Authors:  Hans-Guido Wendel; Elisa De Stanchina; Jordan S Fridman; Abba Malina; Sagarika Ray; Scott Kogan; Carlos Cordon-Cardo; Jerry Pelletier; Scott W Lowe
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

9.  c-Abl phosphorylates Dok1 to promote filopodia during cell spreading.

Authors:  Pamela J Woodring; Jill Meisenhelder; Sam A Johnson; Guo-Lei Zhou; Jeffrey Field; Kavita Shah; Friedhelm Bladt; Tony Pawson; Masaru Niki; Pier Paolo Pandolfi; Jean Y J Wang; Tony Hunter
Journal:  J Cell Biol       Date:  2004-05-17       Impact factor: 10.539

10.  Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.

Authors:  Simon A Hawley; Jérôme Boudeau; Jennifer L Reid; Kirsty J Mustard; Lina Udd; Tomi P Mäkelä; Dario R Alessi; D Grahame Hardie
Journal:  J Biol       Date:  2003-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.